
The Australian competition regulator said on Thursday it will not oppose an A$2.47 billion ($1.67 billion) acquisition of Link Administration Holdings by Canada’s Dye & Durham Ltd, if it divests its existing local business.
The Australian Competition & Consumer Commission (ACCC) said the acquisition would be unlikely to “substantially lessen competition”, assuming the Canadian cloud-based software firm divests its existing local businesses, as stated in Dye & Durham’s court-enforceable pledge.
The deal will give Dye & Durham (D&D) access to share registry firm Link’s prized 42.8% stake in online property settlement firm PEXA Group Ltd, which was the subject of concern for the regulator.
“The ACCC has focussed on ensuring that the post-acquisition market structure does not hinder competition over the longer term,” ACCC Chair Gina Cass-Gottlieb said.
“Ultimately, the ACCC concluded that the proposed acquisition, taking into consideration the divestiture undertaking, would be unlikely to substantially lessen competition.”
The approval comes on the heels of PEXA Group announcing acquisition of a UK-based remortgage processing firm Optima Legal on expectations that rising interest rates prompt people to switch their lenders in search of better rates.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas